Date/Time
Date(s) - 17 Nov 2026
8:00 AM - 9:00 AM
Are you developing a promising cancer-focused technology and seeking funding to advance it toward commercialization? Join the National Cancer Institute’s Small Business Innovation Research Development Center for an informational webinar on how early-stage companies, academic spinouts, and entrepreneurial researchers can access funding and commercialization support from the National Cancer Institute (NCI).
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are a critical source of non-dilutive federal funding for early-stage companies. NCI SBIR/STTR programs provide approximately $200 million annually to US small businesses advancing innovative cancer technologies, including therapeutics, diagnostics, devices, digital health tools, and research technologies. In addition to funding, the NCI SBIR Development Center offers a range of commercialization resources to help small businesses bring their products to market.
Join to learn about:
- SBIR/STTR grant programs at the National Cancer Institute
- Funding opportunities for cancer-focused start-ups and academic spinouts
- Tips for writing competitive SBIR/STTR grant proposals.
- Commercialization resources for applicants and awardees
Workshop attendees will also have the opportunity to request a one-on-one meeting with NCI Program Directors to discuss their technologies and obtain project-specific guidance. Contact Dylan Peay, PhD (dylan@azadvances.org) for the bookings link.
Register Here
Speakers:
Dr. William Bozza is a Program Director at the NCI SBIR Development Center. He manages a portfolio of oncology startups (SBIR & STTR awardees), supporting small businesses in commercializing technologies for cancer diagnosis and treatment. Dr. Bozza is currently leading the Center’s efforts on the Small Business Concept Award for early-stage, high-risk/high-reward technologies targeting rare and pediatric cancers and the Phase II B Strategic Breakthrough Award. He also leads the Program’s Peer Learning and Networking Webinar Series to help SBIR companies learn from peers and foster collaboration. Before joining NCI, Dr. Bozza previously served as a Regulatory Scientist at the FDA specializing in chemistry, manufacturing, and control (CMC) review of drug applications. Dr. Bozza received his doctorate in Biochemistry in 2013 from the University of Delaware, where he was trained as an enzymologist
Dr. Swamy K. Tripurani is a Program Director at the NCI SBIR Development Center. He manages a portfolio of grants and contracts that support small businesses in developing innovative cancer therapeutics, digital health technologies, and therapeutic devices. Dr.Tripurani plays an active role in several center initiatives and serves as NCI’s representative on the trans-NIH REACH program. Before joining the NCI, Dr. Tripurani served as a Senior Research Scientist and Product Quality Assessor for 8 years at the U.S. FDA Center for Drug Evaluation and Research, Office of Pharmaceutical Quality Research, and as a clinical research associate at MD Anderson Cancer Center’s Department of Investigational Cancer Therapeutics. He earned his Ph.D. in Genetics and Developmental Biology from West Virginia University and completed postdoctoral research focused on gynecologic cancers and disorders at Baylor College of Medicine.